PDP1 and diabetic cardiomyopathy: Of interest, stimulating myocardial PDH activity and subsequent glucose oxidation has been shown to improve cardiac function in murine models of diabetic cardiomyopathy, ischemia-reperfusion injury, and heart failure (16–19).